Clinical factors associated with relapse in male alcohol dependents during six-month follow-up

Klinik Psikofarmakoloji Bulteni

Volumn 20, Issue 1, 2010, Pages 14-22

  Evren, Cüneyt ^a   Cetin, Rabia ^a   Durkaya, Mine ^a   Dalbudak, Ercan ^a  

^a Bakirkoy State Hospital for Mental Health and Neurological Disorders   (Turkey)

Author keywords

Alcohol dependence; Craving; Relapse; Therapy

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FOLLOW UP; HOSPITAL PATIENT; HUMAN; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MICHIGAN ALCOHOLISM SCREENING TEST; OUTPATIENT CARE; PATIENT CARE; PENN ALCOHOL CRAVING SCALE; PREDICTION; RELAPSE; REMISSION; SCREENING TEST; SYMPTOM CHECKLIST 90; WITHDRAWAL SYNDROME;

EID: 77957109736     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: 10.1080/10177833.2010.11790629     Document Type: Article

References (60)

1. Miller WR, Walters ST, Bennett ME. How effective is alcoholism treatment in the United States? J Stud Alcohol 2001;62:211-220.
2. Monahan S, Finney J. Explaining abstinence rates following treatment for alcohol abuse. A quantitative synthesis of patient, research design, and treatment effects. Addiction 1996;91:787-805.
3. McLellan AT, Alterman AI, Metzger DS, Grissom GR, Woody GE, Luborsky L, O'Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. J Consult Clin Psychol 1994;62:1141-1158. (Pubitemid 24377643)
4. Booth BM, Curran GM, Han X. Predictors of short-term course of drinking in untreated rural and urban at-risk drinkers: effects of gender, illegal drug use, and psychiatric comorbidity. J Stud Alcohol 2004;65:63-73. (Pubitemid 38200619)
5. Bottlender M, Soyka M. Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. Alcohol Alcohol 2004;39:357-361. (Pubitemid 38968094)
6. Miller WR, Westerberg VS, Harris RJ, Tonigan JS. What predicts relapse? Prospective testing of antecedent models. Addiction 1996;91:155-171.
7. Yates WR, Booth BM, Reed DA, Brown K, Masterson BJ. Descriptive and predictive validity of a high-risk alcoholism relapse model. J Stud Alcohol 1993;54:645-651. (Pubitemid 23318735)
8. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA. Stress, vulnerability, and alcohol relapse. J Stud Alcohol 1995;56:538-545.
9. Connors GJ, Maisto SA, Zywiak WH. Understanding relapse in the broader context of post-treatment functioning. Addiction 1996;91:S173-189.
10. Moss RH, Moss BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 2006; 101: 212-222. (Pubitemid 43351596)
11. Monti PM, Abrams DB, Binkoff JA, Zwick WR., Liepman MR, Nirenberg TD, Rohsenow DR. Communication skills training, communication skills training with family, and cognitive behavioral mood management training for alcoholics. J Stud Alcohol 1990;51:263-270.
12. Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 1997;106:243-250. (Pubitemid 27184745)
13. O'Connor PG, Gottlieb LD, Kraus ML, Segal SR, Horwitz RI. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J Gen Intern Med 1991;6:312-316.
14. Singleton EG, Gorelick DA. Mechanisms of alcohol craving and their clinical implications. In: Recent Developments in Alcoholism, Vol. 14: The consequences of alcoholism. Galanter, M. (ed.), 1998, 177-195. Plenum Press, New York, NY.
15. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000;20:149-171. (Pubitemid 30100430)
16. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 2001;36:249-255. (Pubitemid 32519861)
17. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000;20:173-189. (Pubitemid 30100431)
18. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Research 1999; 89:97-106.
19. Strowing AB. Relapse determinants reported by men treated for alcohol addiction: the prominence of depressed mood. J Subst Abuse Treat 2000;19:469-474.
20. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello JR, Michael J. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 1998;55:259-265.
21. Janowsky DS, Boone A, Morter S, Howe L. Personality and alcohol/substance-use disorder patient relapse and attendance at self-help group meetings. Alcohol Alcohol 1999;34:359-369. (Pubitemid 29295165)
22. First MB, Spitzer RL, Gibbon M, Williams JBW. Stuructured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington D.C. and London: American Psychiatric Press, Inc, 1997.
23. Corapcioglu A, Aydemir O, Yildiz M, Esen A., Koroglu E. DSM-IV Eksen I Bozukluklari (SCID-I) için Yapilandirilmiş Klinik Görüşme, Klinik Versiyon. Ankara. Hekimler Yayin Birliǧi, 1999. (in Turkish)
24. Dag I. Belirti tarama listesi (SCL-90-R) nin üniversite öǧrencileri için güvenirliǧi ve geçerliǧi, (Reliability and validity of Symptom Check List-90-Revised among university students), Turkish Journal of Psychiatry 1991;2: 5-12. (in Turkish)
25. Derogatis LR. SCL-90: Administration, Scoring and Procedure Manual-II for the revised version, Tawson, Clinical Psychometric Research, 1983.
26. Coskunol H, Bagdiken I, Sorias S, Saygili R. Validity and reliability of the Michigan Alcoholism Screening Test (Turkish version). Aegean J Med 1995;34:15-18. (in Turkish)
27. Gibbs LE. Validity and reliability of the Michigan Alcoholism Screening Test: A review. Drug Alcohol Depend 1985;12: 279-285.
28. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
29. Hisli N. Reability and validity of Beck Depression Inventory among university students. Journal of Turkish Psychology 1989;7:3-13. (in Turkish)
30. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893-897. (Pubitemid 19008360)
31. Ulusoy M, Erkmen H, Sahin N. Turkish version of the Beck Anxiety Inventory: Psychometric properties; Journal of Cognitive Psychotherapy; An international quarterly 1998;12:163-172. (Pubitemid 28451158)
32. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999;23:1289-1295. (Pubitemid 29409341)
33. Evren C, Flannery B, Çelik R, Durkaya M, Dalbudak E. Penn Alkol Aşerme Ölçeǧi (PAAÖ) Türkçe Şeklinin Yatarak Tedavi Gören Erkek Alkol Baǧimlisi Hastalarda Geçerliǧi ve Güvenirliǧi. Baǧimlilik Dergisi 2008;9:128-134. (in Turkish)
34. Evren C, Saatçioǧlu Ö, Dalbudak E, Danişmant BS, Çakmak D, Ryan RM. Tedavi Motivasyonu Anketi (TMA) Türkçe Versiyonunun Alkol Baǧimlisi Hastalarda Faktör Yapisi, Geçerliǧi ve Güvenirliǧi. Baǧimlilik Dergisi, 2006; 7: 117-122. (in Turkish)
35. Evren C, Dalbudak E, Cakmak D. Deǧişime Hazir Olma ve Tedavi İsteǧi Ölçeǧi (SOCRATES) Türkçe Versiyonunun Yatarak Tedavi Gören Erkek Alkol Baǧimlisi Hastalarda Faktör Yapisi, Geçerliǧi ve Güvenirliǧi. Klinik Psikofarmakoloji Bülteni 2008;18:84-91. (in Turkish)
36. Cetin R. Alkol baǧimlilarinda travma sonrasi stress bozukluǧu ve kişilik özelliklerinin remisyona etkisi ve remisyonun tedavi motivasyonu ve aşerme ile ilişkisi. Tez Istanbul, 2009. (in Turkish)
37. Soyka M, Hasemann S, Scharfenberg CD, Löhnert B, Bottlender M. New possibilities in treatment and rehabilitation of alcoholdependent patients - a catamnestic study on the efficiency of outpatient treatment programmes demonstrated by a model procedure. Nervenarzt 2003;74:226-234.
38. Addolorato G, Leggio L, Abenavoli L, Gasbarrini G; Alcoholism Treatment Study Group. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav. 2005;30:1209-1224.
39. Gordon SM, Sterling R, Siatkowski C, Raively K, Weinstein S, Hill PC. Inpatient desire to drink as a predictor of relapse to alcohol use following treatment. Am J Addict 2006;15:242-245.
40. Evren C, Durkaya M, Çelik R, Dalbudak E, Çakmak D, Flannery B. Yatarak tedavi gören erkek alkol baǧimlisi hastalarda alkol aşermesinin aleksitimi ve dissosiyasyon ile ilişkisi. Anadolu Psikiyatri Dergisi 2009; 10:165-173
41. Evren C, Çetin R, Durkaya M, Dalbudak E, Çakmak D. Yatarak Tedavi Gören Erkek Alkol Baǧimlisi Hastalarda Alkol Aşermesinin Travma Sonrasi Stres Bozuklugǧu ve Genel Psikopatolojinin Şiddeti ile İlişkisi. Nöro Psikiyatri Arşivi 2009; 46(1):3-7. (in Turkish)
42. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention. An overview of Marlatt's cognitive-behavioral model. Alcohol Res Health. 1999;23:151-160.
43. Fox HC, Bergquist KL, Hong KI, Sinha R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol Clin Exp Res 2007;31:395-403. (Pubitemid 46239271)
44. Sinha R. The role of stress in addiction relapse. Curr Psychiatry Rep 2007;9:388-395.
45. Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM.Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009;34:1198-208.
46. Ornstein P, Cherepon JA. Demographic variables as predictors of alcoholism treatment outcome. J Stud Alcohol 1985;46: 425-432. (Pubitemid 16218263)
47. Jarvis TJ. Implications of gender for alcohol treatment research: a quantitative and qualitative review. Br J Addict 1992;87: 1249-1261.
48. Zywiak WH, Stout RL, Trefry WB, Glasser I, Connors GJ, Maisto SA, Westerberg VS. Alcohol relapse repetition, gender, and predictive validity. J Subst Abuse Treat 2006;30:349-353. (Pubitemid 43729155)
49. Armor DJ, Meshkoff JE. Remission among treated and untreated alcoholics. Adv Subst Abuse 1983;3: 239-269.
50. Marlowe DB, Merikle EP, Kirby KC, Festinger DS, McLellan AT. Multidimensional assessment of perceived treatment entry pressures among substance abusers. Psychol Addict Behav 2001;15:97-108.
51. Isenhart CE. Pretreatment readiness for change in male alcohol dependent subjects: predictors of one-year follow-up status. J Stud Alcohol 1997;58:351-357.
52. Oslin DW, Cary M, Slaymaker V, Colleran C, Blow FC. Daily ratings measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking. Drug Alcohol Depend 2009;103:131-136.
53. Bottlender M, Soyka M. Efficacy of an intensive outpatient rehabilitation program in alcoholism: predictors of outcome 6 months after treatment. Eur Addict Res 2005;11:132-137. (Pubitemid 40910981)
54. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 2002;59:375-380. (Pubitemid 34275256)
55. Willinger U, Lenzinger E, Hornik K, Fischer G, Schönbeck G, Aschauer HN, Meszaros K; European fluvoxamine in alcoholism study group. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol 2002;37:609-612.
56. Mundle G, Ackermann K, Günthner A, Munkes J, Mann K. Treatment outcome in alcoholism - a comparison of self-report and the biological markers carbohydrate-deficient transferrin and gamma-glutamyl transferase. Eur Addict Res 1999;5:91-96. (Pubitemid 29312954)
57. Babor TF, Steinberg K, Anton R, Del Boca F. Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol. 2000;61:55-63. (Pubitemid 30005059)
58. Boening JAL, Lesch OM, Spanagl R, Wolfgramm J, Narita M, Sinclair D, Mason BJ, Wiesbeck GA. Pharmacological relapse prevention in alcohol dependence: From animal models to clinical trials. Alcohol Clin Exp Res 2001;25 (Suppl.5):127-131 .
59. Soyka M, Chick J. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. Am J Addict 2003;12 Suppl 1:S69-80.
60. Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999;67:563-570.